Is Joe Rogan too confident about ibogaine?
Healthcare,Donald Trump,FDA,Joe Rogan,Health,Public Health,Drugs,Psychedelics,Executive Orders,Veterans
From the Center
AllSides Media Bias Rating: Center
On Saturday, Donald Trump signed a major drug-policy executive order directing the fast-tracking of psychedelics such as ibogaine as potential treatments for severe mental health conditions, including addiction and PTSD.
Research into novel treatments is important. But so far the evidence supporting the miraculous claims made by advocates such as Joe Rogan — who says he played a central role in getting Trump to sign this order — is weak.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
US Reports Highest Number of Measles Cases in 35 Years, Risks Losing Elimination Status
July 23rd, 2026
Headline Roundup
CDC Confirms Record Cyclospora Cases as FDA Investigates Taylor Farms Lettuce
July 22nd, 2026
News
Tracking Trump’s Campaign Promises
AllSides Staff
July 24th, 2026
Red Blue Translator
Big Pharma
More News about Healthcare
News from the Left
News from the Center
News from the Right
No. 2 DOJ official slams judge for blocking vaccine changes hours after appeals court overturned him
Just The News